These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21098577)

  • 1. Natriuretic peptide-guided management by the general practitioner: how to interpret the SIGNAL.
    Drexler B; Mueller C
    Eur J Heart Fail; 2010 Dec; 12(12):1265-7. PubMed ID: 21098577
    [No Abstract]   [Full Text] [Related]  

  • 2. Amino-terminal pro-brain natriuretic peptide: a biomarker for diagnosis, prognosis and management of heart failure.
    Morello AM; Januzzi JL
    Expert Rev Mol Diagn; 2006 Sep; 6(5):649-62. PubMed ID: 17009901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natriuretic peptide-guided management of acutely destabilized heart failure: rationale and treatment algorithm.
    Bhardwaj A; Januzzi JL
    Crit Pathw Cardiol; 2009 Dec; 8(4):146-50. PubMed ID: 19952548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine measurement of natriuretic peptide to guide the diagnosis and management of chronic heart failure.
    Januzzi JL; Maisel AS
    Circulation; 2004 Jun; 109(25):e325-6; author reply e325-6. PubMed ID: 15226236
    [No Abstract]   [Full Text] [Related]  

  • 5. Improved pharmacological therapy of chronic heart failure in primary care: a randomized Study of NT-proBNP Guided Management of Heart Failure--SIGNAL-HF (Swedish Intervention study--Guidelines and NT-proBNP AnaLysis in Heart Failure).
    Persson H; Erntell H; Eriksson B; Johansson G; Swedberg K; Dahlström U
    Eur J Heart Fail; 2010 Dec; 12(12):1300-8. PubMed ID: 20876734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain natriuretic peptide in the contemporary management of congestive heart failure.
    Wasywich CA; Whalley GA; Doughty RN
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):71-84. PubMed ID: 15723576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma brain natriuretic peptide-guided therapy not yet justified.
    Hoppe UC
    J Am Coll Cardiol; 2007 Nov; 50(21):2097-8; author reply 2098-9. PubMed ID: 18021882
    [No Abstract]   [Full Text] [Related]  

  • 8. B-type natriuretic peptides: applications for heart failure management in 2005.
    Troughton RW; Richards M
    Intern Med J; 2005 Jul; 35(7):377-9. PubMed ID: 15958104
    [No Abstract]   [Full Text] [Related]  

  • 9. Routine measurement of natriuretic peptide to guide the diagnosis and management of chronic heart failure.
    Troughton RW; Richards AM; Yandle TG; Nicholls G
    Circulation; 2004 Jun; 109(25):e325-6; author reply e325-6. PubMed ID: 15232832
    [No Abstract]   [Full Text] [Related]  

  • 10. B-type natriuretic peptide in the management of patients with congestive heart failure.
    Menon PV; Glancy DL
    J La State Med Soc; 2004; 156(2):78-82. PubMed ID: 15106865
    [No Abstract]   [Full Text] [Related]  

  • 11. Limited value of brain natriuretic peptide as a prognostic marker in acute heart failure--a meta-analysis.
    Binder A; Seropian IM; Kontos MC; Van Tassell BW; Biondi-Zoccai GG; Abbate A
    Int J Cardiol; 2010 Dec; 145(3):540-1. PubMed ID: 20541821
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of the brain natriuretic peptide in heart failure management.
    Kalsmith BM
    Circ Heart Fail; 2009 Jul; 2(4):379. PubMed ID: 19808363
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognosis in heart failure with a normal ejection fraction.
    Cleland JG; Taylor J; Tendera M
    N Engl J Med; 2007 Aug; 357(8):829-30. PubMed ID: 17715420
    [No Abstract]   [Full Text] [Related]  

  • 14. Circulating natriuretic peptide levels in acute heart failure.
    Maisel A
    Rev Cardiovasc Med; 2007; 8 Suppl 5():S13-21. PubMed ID: 18192949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical performance vs clinical use of natriuretic peptide measurements.
    Andrade DM; Vidigal PG; Eloi-Santos SM
    Arch Intern Med; 2010 Jul; 170(14):1274; author reply 1275. PubMed ID: 20660853
    [No Abstract]   [Full Text] [Related]  

  • 16. Natriuretic peptide-guided management of patients with heart failure: a decade of progress but still a controversy.
    Baibars M; Ibrahim A; Fang JC; Sipahi I
    Future Cardiol; 2010 Nov; 6(6):743-7. PubMed ID: 21142628
    [No Abstract]   [Full Text] [Related]  

  • 17. Brain natriuretic peptide and optimal management of heart failure.
    Li N; Wang JA
    J Zhejiang Univ Sci B; 2005 Sep; 6(9):877-84. PubMed ID: 16130189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing prognosis in heart failure: is hepatocyte growth factor the next B-type natriuretic peptide?
    Katz JN; Drazner MH
    Am Heart J; 2005 Jul; 150(1):1-3. PubMed ID: 16084142
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations].
    Latini R; Masson S
    Ital Heart J Suppl; 2000 Aug; 1(8):1068-9. PubMed ID: 10993019
    [No Abstract]   [Full Text] [Related]  

  • 20. Utility of brain natriuretic peptide (BNP) measurement in cardiovascular disease.
    Sullivan DR; West M; Jeremy R
    Heart Lung Circ; 2005 Jun; 14(2):78-84. PubMed ID: 16352258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.